Your browser doesn't support javascript.
Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru.
Soriano-Moreno, David R; Fernandez-Guzman, Daniel; Sangster-Carrasco, Lucero; Quispe-Vicuña, Carlos; Grados-Espinoza, Pamela; Ccami-Bernal, Fabricio; Morocho-Alburqueque, Noelia; Coba-Villan, Naomi; Velasquez-Fernandez, Randy; Nieto-Gutierrez, Wendy.
  • Soriano-Moreno DR; From the Unidad de Investigación Clínica y Epidemiológica, Escuela de Medicina, Universidad Peruana Unión, Lima.
  • Sangster-Carrasco L; Universidad Peruana de Ciencias Aplicadas, Facultad de Medicina.
  • Quispe-Vicuña C; Sociedad Científica San Fernando, Universidad Nacional Mayor de San Marcos, Lima.
  • Grados-Espinoza P; Universidad Nacional Daniel Alcides Carrión, Facultad de Medicina Humana, Pasco.
  • Ccami-Bernal F; Universidad Nacional de San Agustín de Arequipa, Arequipa.
  • Morocho-Alburqueque N; Sociedad Científica de Estudiantes de Medicina de la Universidad Nacional de Piura (SOCIEMUNP), Piura, Peru.
  • Coba-Villan N; Universidad Nacional de Cajamarca, Cajamarca.
  • Nieto-Gutierrez W; Universidad San Ignacio de Loyola, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Lima, Peru.
J Patient Saf ; 18(8): e1189-e1195, 2022 Dec 01.
Article in English | MEDLINE | ID: covidwho-1948607
ABSTRACT

OBJECTIVE:

This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru.

METHODS:

An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method.

RESULTS:

Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65).

CONCLUSIONS:

Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Country/Region as subject: South America / Peru Language: English Journal: J Patient Saf Journal subject: Health Services Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans Country/Region as subject: South America / Peru Language: English Journal: J Patient Saf Journal subject: Health Services Year: 2022 Document Type: Article